Guest Contributors

Shirley Liu Shirley Liu, Professor of Biostatisitcs at Harvard, Co-Director of the Center for Fuctional Cancer Epigenetics at the Dana Farber Cancer Institute	Matt Loose Matt Loose, Professor of Developmental and Computational Biology, Faculty of Medicine & Health Sciences, University of Nottingham	Lu, Yi, PhD Professor, University of Illinois
Lustig, Kevin, PhD CEO, Assay Depot	Gholson Lyon @GholsonLyon	Elaine Lyon Clinical Services Lab Director at HudsonAlpha Institute for Biotechnology
Sandy Macrae Sandy Macrae, CEO of Sangamo	Maderis, Gail President and CEO, BayBio	Malow, Brian Science Comedian
Elizabeth Mansfield Deputy Office Director of Personalized Medicine, OIR, FDA	Marco Marra Professor and Head, Department of Medical Genetics, University of British Columbia	Annie Martin Annie Martin, SVP, Global Head of Precision Medicine, Novartis
Trey Martin Chief Operating Officer, IDT	Martin, Hugh former CEO, Pacific Biosciences	Rodrigo Martinez Rodrigo Martinez, Chief Marketing and Design Officer at Veritas
Marton, Laurence, MD Program Chair, PMWC	Christopher Mason	Nola Masterson Founder, Science Futures
Ellen Matloff President and CEO, My Gene Counsel	Charles Matthews VP, Boston Healthcare	Shannon McCall Associate Professor, Leader of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University
Tim McDaniel Dir of Scientific Research, Illumina	Brian McKelligon Brian McKelligon, CEO at Akoya Biosciences	Mcleod, Howard, Pharm D Director, PGI
Matt McLoughlin Matt McLoughlin, VP of Compliance at Scientist.com